Protein Polymer Technologies, Inc. (OTCBB: PPTI), a biotechnology device company that is a pioneer in protein design and synthesis, announced today that it has discontinued discussions of a merger with Thuris Corporation, a privately held biopharmaceutical company. “Both companies have agreed to discontinue merger discussions at this time,” said William N. Plamondon III, Chief Executive Officer of Protein Polymer Technologies.
